This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Donald R. Sweeney, MD, PhD; James W. Maas, MD; George R. Heninger, MD

Arch Gen Psychiatry. 1978;35(12):1418-1423.

Abstract
• Measurement of urinary 3-methoxy-4-hydroxyphenethylene glycol (MHPG) levels has been suggested as possibly being important in elucidating the role of central noradrenergic function in affective illnesses. The influence on urinary MHPG excretion of the state variables of physical activity and stress has not been clearly defined in previous studies. During a baseline medication-free period, 24 hospitalized depressed female patients underwent a five-day protocol including an eight-hour period of either enhanced or restricted activity. Throughout the protocol, independent measurements of telemetered mobility and state anxiety were obtained. There were no significant effects of physical activity on urinary MHPG levels. Furthermore, baseline urinary MHPG levels and baseline state anxiety did not covary significantly. However, within-individual analyses yielded a highly significant relationship between changes in urinary MHPG levels and changes in state anxiety. The data suggested that those patients with lower baseline MHPG levels were those more prone to experience increased anxiety under enviornmentally "activating" circumstances.

Author Affiliations
From the Department of Psychiatry, Yale University, New Haven, Conn. Dr Sweeney is now with Fair Oaks Hospital, Summit, NJ.

Footnotes
Accepted for publication Feb 24, 1978.

Reprint requests to Fair Oaks Hospital, 19 Prospect St, Summit, NJ 07901 (Dr Sweeney).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of the Amygdala in the Coordination of Behavioral, Neuroendocrine, and Prefrontal Cortical Monoamine Responses to Psychological Stress in the Rat
Goldstein et al.
J. Neurosci. 1996;16:4787-4798.
ABSTRACT | FULL TEXT  

Blunted Growth Hormone Response to Clonidine in Patients With Generalized Anxiety Disorder
Abelson et al.
Arch Gen Psychiatry 1991;48:157-162.
ABSTRACT  

Plasma 3-Methoxy-4-Hydroxyphenylglycol Changes Associated With Clinical State and Schizophrenic Subtype
Ko et al.
Arch Gen Psychiatry 1988;45:842-846.
ABSTRACT  

High Intercorrelations Among Urinary Outputs of Norepinephrine and Its Major Metabolites: A Replication in Depressed Patients and Controls
Roy et al.
Arch Gen Psychiatry 1988;45:158-161.
ABSTRACT  

Noradrenergic Function in Schizophrenia
Glazer et al.
Arch Gen Psychiatry 1987;44:898-904.
ABSTRACT  

Cerebrospinal Fluid Amine Metabolites: Relations`phips With Behavioral Measurements in Depressed, Manic, and Healthy Control Subjects
Redmond et al.
Arch Gen Psychiatry 1986;43:938-947.
ABSTRACT  

Noradrenergic Function in Panic Anxiety: Effects of Yohimbine in Healthy Subjects and Patients With Agoraphobia and Panic Disorder
Charney et al.
Arch Gen Psychiatry 1984;41:751-763.
ABSTRACT  

Urinary 3-Methoxy-4-Hydroxyphenylglycol and Major Affective Disorders: A Replication and New Findings
Muscettola et al.
Arch Gen Psychiatry 1984;41:337-342.
ABSTRACT  

Increased Plasma MHPG in Dexamethasone-Resistant Depressed Patients
Jimerson et al.
Arch Gen Psychiatry 1983;40:173-176.
ABSTRACT  

High Correlation of Norepinephrine and Its Major Metabolite Excretion Rates
Linnoila et al.
Arch Gen Psychiatry 1982;39:521-523.
ABSTRACT  

Plasma MHPG in Rapid Cyclers and Healthy Twins
Jimerson et al.
Arch Gen Psychiatry 1981;38:1287-1290.
ABSTRACT  

Diagnosis of Depression in the 1980s
Gold et al.
JAMA 1981;245:1562-1564.
ABSTRACT  

Plasma Free and Conjugated MHPG in Psychiatric Patients: A Pilot Study
Sweeney et al.
Arch Gen Psychiatry 1980;37:1100-1103.
ABSTRACT